View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | United States |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2050-09-15 |
| Par Value | 2000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 750.00 |
| Coupon | 2.8 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 750 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Regeneron Pharmaceuticals, Inc. corporate note has a 2.80% fixed rate coupon paid on a semi-annual basis. It was issued on August 12, 2020 with an issue size of 750.00 million USD and matures on September 15, 2050 with a last coupon date of March 15, 2050. |
Regeneron Pharmaceuticals, Inc., founded in 1988 and headquartered in Tarrytown, New York, is a leading biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative medicines for serious diseases. The company's key products include EYLEA, a treatment for eye diseases, and Dupixent, which targets various allergic conditions and asthma.